Literature DB >> 18262654

Serious life events among resistant and non-resistant MDD patients.

D Amital1, L Fostick, A Silberman, M Beckman, B Spivak.   

Abstract

BACKGROUND: Over 60% of patients with major depressive disorder (MDD) do not respond fully to therapy. Half of them eventually will not respond at all and will be referred to as treatment resistant depression (TRD) patients. Stressful life events were found to be associated with MDD and were also found to affect the course of the disease. We hypothesize that negative life events might be an independent risk factor for TRD.
METHODS: One hundred and seven unipolar MDD patients, all treated for at least 4 weeks, were enrolled in the study. Patients were assessed on their psychiatric and medical history, and seven categories of stressful life events.
RESULTS: 39.3% of participants were defined as TRD patients and 60.7% as non-TRD. TRD patients had more severe depression, more past suicide attempts, more hospitalizations, longer episodes, and received more benzodiazepines, antipsychotics, and ECT. Job loss and financial stress were more prevalent among the TRD group. Overall, the TRD patients had more negative life events than responders. LIMITATIONS: This is a retrospective study. In addition, the definition of TRD was done dichotomically, therefore the association between number of stressful life events and the degree of resistance was not tested.
CONCLUSIONS: Job loss and financial distress were found to predict TRD. The loss of a parent and severe health conditions were not associated with TRD, suggesting that events affecting the development of MDD, do not necessarily affect the treatment outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262654     DOI: 10.1016/j.jad.2008.01.006

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  21 in total

1.  Effect of obstructive sleep apnea on response to cognitive behavior therapy for depression after an acute myocardial infarction.

Authors:  Kenneth E Freedland; Robert M Carney; Junichiro Hayano; Brian C Steinmeyer; Rebecca L Reese; Annelieke M Roest
Journal:  J Psychosom Res       Date:  2012-01-28       Impact factor: 3.006

Review 2.  Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

3.  Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.

Authors:  Laura Grosse; Livia A Carvalho; Tom K Birkenhager; Witte J Hoogendijk; Steven A Kushner; Hemmo A Drexhage; Veerle Bergink
Journal:  Psychopharmacology (Berl)       Date:  2015-05-08       Impact factor: 4.530

4.  Analyzing Non-verbal Behavior Throughout Recovery in a Sample of Depressed Patients Receiving Deep Brain Stimulation.

Authors:  Micaela V McCall; Patricio Riva-Posse; Steven J Garlow; Helen S Mayberg; Andrea L Crowell
Journal:  Neurol Psychiatry Brain Res       Date:  2020-06-11

5.  Clinical predictors of depression treatment outcomes in patients with coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland; Brian C Steinmeyer; Eugene H Rubin; Michael W Rich
Journal:  J Psychosom Res       Date:  2016-07-19       Impact factor: 3.006

Review 6.  Depression, stress, and anhedonia: toward a synthesis and integrated model.

Authors:  Diego A Pizzagalli
Journal:  Annu Rev Clin Psychol       Date:  2014       Impact factor: 18.561

7.  The lack of association between components of metabolic syndrome and treatment resistance in depression.

Authors:  Marina Sagud; Alma Mihaljevic-Peles; Suzana Uzun; Bjanka Vuksan Cusa; Oliver Kozumplik; Suzan Kudlek-Mikulic; Maja Mustapic; Ivan Barisic; Dorotea Muck-Seler; Nela Pivac
Journal:  Psychopharmacology (Berl)       Date:  2013-04-12       Impact factor: 4.530

Review 8.  Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy.

Authors:  Charles F Zorumski; Peter Nagele; Steven Mennerick; Charles R Conway
Journal:  Front Psychiatry       Date:  2015-12-09       Impact factor: 4.157

9.  Abnormalities of cortical-limbic-cerebellar white matter networks may contribute to treatment-resistant depression: a diffusion tensor imaging study.

Authors:  Hong-jun Peng; Hui-rong Zheng; Yu-ping Ning; Yan Zhang; Bao-ci Shan; Li Zhang; Hai-chen Yang; Jun Liu; Ze-xuan Li; Jian-song Zhou; Zhi-jun Zhang; Ling-jiang Li
Journal:  BMC Psychiatry       Date:  2013-03-02       Impact factor: 3.630

10.  Approaches to understanding and addressing treatment-resistant depression: a scoping review.

Authors:  Emily Jenkins; Elliot M Goldner
Journal:  Depress Res Treat       Date:  2012-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.